HHMI
ABBV icon

Howard Hughes Medical Institute’s AbbVie ABBV Stock Holding History

Howard Hughes Medical Institute’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-381
Closed -$87.1K – 33
2025
Q4 		$87.1K Buy
381
+1
+0.3% +$228 0.05% 20
2025
Q3 		$88K Sell
380
-1
-0.3% -$204 0.05% 22
2025
Q2 		$70.7K Buy
+381
New +$70.8K 0.03% 24
2015
Q1 		– Sell
-10,969
Closed -$718K – 163
2014
Q4 		$718K Buy
+10,969
New +$692K 0.19% 71

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Howard Hughes Medical Institute's ABBV Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 381 shares — an estimated $87.1K sold.

Howard Hughes Medical Institute first reported a position in ABBV in Q4 2014 and held it in 4 quarters. The position peaked at $718K in Q4 2014. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 381 AbbVie shares in Q1 2026, an estimated $87.1K.
  • Howard Hughes Medical Institute first reported a position in AbbVie in Q4 2014 and held it in 4 quarters.
  • Howard Hughes Medical Institute's AbbVie position peaked at $718K in Q4 2014.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.